Despite the headlines, covid-19 vaccines remain more widely accessible in the US than in the UK. Owen Dyer investigatesUS health secretary Robert F Kennedy Jr recently moved to restrict access to covid vaccination in the apparent name of safety. On 20 September the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP)—purged by Kennedy in June and replaced with new members criticised for holding vaccine sceptic views1—voted on their covid vaccine recommendations for the coming year.2The committee stopped short of making a routine recommendation and instead framed covid-19 vaccination as a matter of “individual choice” for all people aged 6 months or older, while noting that the benefits are greater for older adults and people with risk factors.This made the US the first high income country to drop a universal recommendation for covid-19 vaccination.And, working amid a torrent of negative press coverage, Kennedy’s panel narrowly balked, in a 7-6 vote, at taking the one measure that public health experts most feared: requiring a doctor’s prescription for a covid-19 shot.In reality, the committee had been defanged before it even sat. The largest association of US health insurers, AHIP (America’s Health Insurance Plans), announced on 16 September that it will continue to follow the recommendations of the former, pre-purge committee.It declared, “Health plans will continue to cover all ACIP recommended immunisations that were recommended as of 1 September 2025, including updated formulations of the covid-19 and influenza vaccines, with no cost sharing for patients through the end of 2026.”1 The country’s biggest insurer, UnitedHealth Group, not an AHIP member, also swiftly followed suit.“The evidence based approach to coverage of immunisations will remain consistent,” proclaimed AHIP, in what former Tom Frieden, director of the Centers for Disease Control and …
Owen Dyer
Geo Focus
Coverage Attributes:
BetaThemes Covered:


Not enough data
Pitching Insights
Owen Dyer's coverage spans healthcare, pharmaceuticals, government & politics, and health-related issues. His articles often include announcements and cite data to support his reporting.
Given the diverse range of topics covered by Owen, experts in public health policy, epidemiology, global healthcare systems, and political science could provide valuable insights for his articles. Additionally, professionals with expertise in pandemic response strategies or those who can offer unique perspectives on global health crises may find their expertise relevant to his coverage.
As Owen covers a wide array of international stories related to pandemics such as Covid-19 and its variants along with broader global health issues; sources from various countries with firsthand experiences dealing with these topics would be pertinent for potential outreach.
This information evolves through artificial intelligence and human feedback. Improve this profile .












